Exogene
PrivateLast Round
Grant
Oct 15, 2025
Total Funding Raised
$5.55M
Company Overview
Exogene operates in Healthcare & Life Sciences and is based in Oxford. Its latest recorded funding round was a Grant round in October 2025.
Exogene is a biotechnology company that utilizes an artificial intelligence platform for the discovery and development of T-cell receptor (TCR)-based cell therapies for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Exogene Comparables
Compare Exogene with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Synteny | 93% | |
| Etcembly | 91% | |
| ImmunoScape | 77% |
For institutional investors. Book with your work email.
Exogene Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 15, 2025 | ||||
| Convertible Debt | Oct 10, 2025 | ||||
| Seed | Apr 28, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Exogene Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KQ Labs | Seed |
| Selvedge Venture | Seed |
| R42 Group | Seed |
| Entrepreneurs First | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2025
Added Immunocore Ltd, a mid-market biotechnology company, as a customer.
- Apr 28, 2022
$2M round led by Selvedge Venture.
For institutional investors. Book with your work email.
Exogene Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Exogene's valuation, stock price, and market status.
Is Exogene a public or private company?
Exogene is a private company.
What is the current stock price of Exogene?
Exogene is a private company, so its shares have no public market price. Caplight tracks Exogene's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Exogene worth (valuation)?
Valuation information for Exogene is not publicly available.
Can I buy Exogene stock?
Exogene shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Exogene's last funding round?
Exogene's most recent funding round was Grant on October 15, 2025.
Who are the main investors in Exogene?
Key investors in Exogene include Selvedge Venture.
Will Exogene IPO soon?
No public IPO plans have been announced for Exogene.
How can I track Exogene secondary market activity?
Caplight tracks bids, offers, and trades in Exogene's shares on secondary markets.